The field of public health genomics has exploded over the last several years as more and more states are collaborating around cost-efficient, evidence-based methods to enhance cancer screening and prevention efforts. Join the National Cancer Institute and Research to Reality (R2R) on April 16th as we explore opportunities and advances in this exciting field and the opportunities for collaboration between state and local health departments, cancer registries, and research institutions, to improve the care and programs provided across the states.
April’s cyber-seminar will feature three partners who are working together around several exciting public health genomic initiatives in Michigan. Debra Duquette from the Michigan Department of Community Health will provide an overview of how Michigan, as well as several other states, are creating innovative initiatives in genomics through cooperative agreements, collaborations with cancer registries, and will share some lessons learned relevant to other states/organizations looking to develop, fund, and implement similar initiatives in their own states.
Glenn Copeland, Director of the Michigan Cancer Surveillance Program and Michigan State Cancer Registrar, and Director of the Michigan Birth Defects Registries, will describe the specific effort the Cancer Registry has done to create a bi-directional reporting system and its role in developing and improving cancer control interventions and programs.
Finally, Dr. Maria Katapodi, University of Michigan School of Nursing, will discuss the opportunities for, and role of researchers, in public health genomics research and practice. She will discuss a recent research study exploring how to improve adherence to screening guidelines with young breast cancer survivors and their families.
Additionally we will be joined by representatives from Connecticut (Joan Foland and Beverly Burke), Colorado (Dr. Jan Lowery and Randi Rycroft), and Florida (Dr. Tuya Pal) for the question and answer portion of the webinar so we can also learn from the exciting work those states are doing in the arena of public health genomics.